Pharmacists in La Crosse, Wisconsin


93 Pharmacists found in La Crosse
male pharmacist

Robert Marlin Schwandt, RPH


Pharmacist
N2014 Valley Rd, La Crosse, WI 54601
608-788-5298     608-775-8598

male pharmacist

Roger Eric Overton, RPH


Pharmacist
4622 Mormon Coulee Rd, La Crosse, WI 54601
608-788-9146     608-788-9144

male pharmacist

Mr. Ryan R Holte, RPH


Pharmacist
1836 South Ave, La Crosse, WI 54601
608-782-7300    



male pharmacist

Ryan Barfknecht


Pharmacist
4344 Mormon Coulee Rd, La Crosse, WI 54601
608-788-8860     608-788-5790

female pharmacist

Samantha Jo White, PHARMD


Pharmacist
1900 South Ave, La Crosse, WI 54601
800-362-9567    

male pharmacist

Scott Horn, PHARM. D.


Pharmacist
4622 Mormon Coulee Rd, La Crosse, WI 54601
608-788-9146    

female pharmacist

Stephanie Ann Belling, RPH


Pharmacist
528 Cass St, La Crosse, WI 54601
608-784-9922     608-784-2212

male pharmacist

Mr. Steven J Von Seht, RPH


Pharmacist
1836 South Ave, La Crosse, WI 54601
608-782-7300    

female pharmacist

Terri Nelson


Pharmacist
4622 Mormon Coulee Rd, La Crosse, WI 54601
608-788-9146    

female pharmacist

Dr. Tricia Lyn Dissmore, RPH, PHARMD


Pharmacist - Pharmacotherapy
800 West Ave S, Skemp Clinic Pharmacy, La Crosse, WI 54601
608-392-9855    

female pharmacist

Trisha Stroyny, PHARMD


Pharmacist
2400 Rose St, La Crosse, WI 54603
608-781-3300    

female pharmacist

Victoria Schroeder, PHARMD


Pharmacist
4622 Mormon Coulee Rd, La Crosse, WI 54601
608-788-9146    

male pharmacist

Zachary Alan Jonett, PHARM.D


Pharmacist
900 West Ave S, La Crosse, WI 54601
608-796-2058    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.